Literature DB >> 3936166

A combination of calcium ionophore and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) stimulates the growth of purified resting B cells.

G R Guy, C M Bunce, J Gordon, R H Michell, G Brown.   

Abstract

In this study we investigated whether the calcium ionophores A23187 and ionomycin can act synergistically with the phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) to stimulate the growth of resting B lymphocytes purified from human tonsil cells. Ionomycin, A23187, and TPA added separately to cultures at doses of 0.4-1.6 micrograms/ml, 0.2-0.8 micrograms/ml, and 0.05-0.25 ng/ml respectively, did not induce DNA synthesis in resting B lymphocytes. In contrast, calcium ionophores at concentrations of 0.4-1.6 micrograms/ml ionomycin and 0.2-0.8 micrograms/ml A23187, in the presence of 0.05-4 ng/ml TPA, induced marked DNA synthesis and B-cell proliferation, as shown by analyses of incorporation of [3H]thymidine, growth kinetics, and the percentage of cells in the S and G2 + M phases of the cell cycle. These results show that the synergistic effects of calcium ionophores and TPA can bypass the requirement for antigen and exogenous growth factors in B-cell activation. These observations are similar to those obtained from studies of T lymphocytes by other workers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936166     DOI: 10.1111/j.1365-3083.1985.tb01919.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  13 in total

1.  Impaired proliferative responses of peripheral blood B cells from splenectomized subjects to phorbol ester and ionophore.

Authors:  P N Foster; L K Trejdosiewicz
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Control of human B-lymphocyte replication. I. Characterization of novel activation states that precede the entry of G0 B cells into cycle.

Authors:  L Walker; G Guy; G Brown; M Rowe; A E Milner; J Gordon
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

Review 3.  An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes.

Authors:  S L King
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

4.  Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth.

Authors:  J Gordon; L Walker; G Guy; G Brown; M Rowe; A Rickinson
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

5.  Phorbol ester and calcium ionophore are sufficient to promote cell replication in cultures of quiescent human B lymphocytes.

Authors:  L Flores-Romo; D Foster; G R Guy; J Gordon
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

6.  Mitogenic stimulation of human B lymphocytes via the inositol phospholipid 'dual pathway' of signalling requires persistent activation of both second messenger arms.

Authors:  J Gordon; G R Guy; M J Millsum
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

7.  Extracellular human immunodeficiency virus type 1 Tat protein is associated with an increase in both NF-kappa B binding and protein kinase C activity in primary human astrocytes.

Authors:  K Conant; M Ma; A Nath; E O Major
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.

Authors:  P Engel; J Inglés; O de la Calle; T Gallart
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

9.  Differential responsiveness of human B lymphocytes to phorbol ester and calcium ionophore based on their state of activation.

Authors:  J Inglés; P Engel; O De La Calle; T Gallart
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

10.  Activation and proliferation signals in mouse B cells. IX. Protein kinase C activators synergize with non-mitogenic anti-immunoglobulin antibodies to drive B cells into G1.

Authors:  M K Bijsterbosch; J B McLaughlin; M Holman; G G Klaus
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.